<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17183" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Addison Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Munir</surname>
            <given-names>Sadaf</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Quintanilla Rodriguez</surname>
            <given-names>Bryan S.</given-names>
          </name>
          <aff>New York Medical College - Metropolitan Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Waseem</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>Weill Cornell Medicine New York and New York Medical College, Valhalla NY</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sadaf Munir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bryan Quintanilla Rodriguez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Waseem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17183.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Addison disease, also known as&#x000a0;autoimmune adrenalitis, is an acquired primary adrenal insufficiency.&#x000a0;Primary adrenal insufficiency is termed Addison disease when an autoimmune process causes the condition and is a rare but potentially life-threatening emergency condition. Addison disease results from the destruction of the bilateral adrenal cortex, leading to decreased adrenocortical hormones, including cortisol, aldosterone, and androgens. Addison disease's insidious course of action usually presents with glucocorticoid deficiency followed by mineralocorticoid. However, the condition can also present acutely,&#x000a0;often triggered by intercurrent illness. The presentation of adrenal insufficiency depends on the rate and extent of adrenal function involvement. The most common cause of primary adrenal insufficiency is Addison disease, associated with increased levels of 21-hydroxylase antibodies.<xref ref-type="bibr" rid="article-17183.r1">[1]</xref><xref ref-type="bibr" rid="article-17183.r2">[2]</xref></p>
        <p>Addison disease usually manifests as an insidious and gradual onset of nonspecific symptoms, often resulting in a delayed diagnosis. The symptoms may worsen over a period, which makes early recognition difficult. A high clinical suspicion should be maintained to avoid misdiagnosis.<xref ref-type="bibr" rid="article-17183.r3">[22]</xref>&#x000a0;In many cases, the diagnosis is made only after the patient presents with an acute adrenal crisis manifesting with hypotension, hyponatremia, hyperkalemia, and hypoglycemia.&#x000a0;The diagnosis is established by demonstrating low cortisol and aldosterone levels, high renin levels, and a&#x000a0;blunt cortisol response with ACTH stimulation.&#x000a0;Addison crisis is a severe endocrine emergency; immediate recognition and treatment are required. For stabilized patients diagnosed with Addison disease, life-long treatment with hormonal replacement is needed. Maintenance therapy aims to provide a replacement&#x000a0;to maintain a physiologic glucocorticoid and mineralocorticoid level.&#x000a0;This activity for healthcare professionals aims to enhance learners' competence in selecting appropriate diagnostic tests, managing Addison disease, and fostering effective interprofessional teamwork to improve outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;potential causes of Addison disease.</p></list-item><list-item><p>Determine&#x000a0;when Addison disease should be included in the differential diagnosis.</p></list-item><list-item><p>Develop a management plan for patients with Addison disease.</p></list-item><list-item><p>Collaborate with the interprofessional team to educate, treat, and manage patients with&#x000a0;Addison disease and improve their outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17183&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17183">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17183.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Addison disease, also known as&#x000a0;autoimmune adrenalitis, is an acquired primary adrenal insufficiency.&#x000a0;Primary adrenal insufficiency is termed Addison disease when an autoimmune process causes the condition and is a rare but potentially life-threatening emergency condition. Addison disease results from the destruction of the bilateral adrenal cortex, leading to decreased adrenocortical hormones, including cortisol, aldosterone, and androgens. Addison disease's insidious course of action usually presents with glucocorticoid deficiency followed by mineralocorticoid. However, the condition can also present acutely,&#x000a0;often triggered by intercurrent illness. The presentation of adrenal insufficiency depends on the rate and extent of adrenal function involvement. The most common cause of primary adrenal insufficiency is Addison disease, associated with increased levels of 21-hydroxylase antibodies.<xref ref-type="bibr" rid="article-17183.r1">[1]</xref><xref ref-type="bibr" rid="article-17183.r2">[2]</xref></p>
        <p>Addison disease usually manifests as an insidious and gradual onset of nonspecific symptoms, often resulting in a delayed diagnosis. The symptoms may worsen over a period, which makes early recognition difficult. A high clinical suspicion should be maintained to avoid misdiagnosis.<xref ref-type="bibr" rid="article-17183.r3">[3]</xref>&#x000a0;In many cases, the diagnosis is made only after the patient presents with an acute adrenal crisis manifesting with hypotension, hyponatremia, hyperkalemia, and hypoglycemia.&#x000a0;The diagnosis is established by demonstrating low cortisol and aldosterone levels, high renin levels, and a&#x000a0;blunt cortisol response with ACTH stimulation.&#x000a0;Addison crisis is a severe endocrine emergency; immediate recognition and treatment are required. For stabilized patients diagnosed with Addison disease, life-long treatment with hormonal replacement is needed. Maintenance therapy aims to provide a replacement&#x000a0;to maintain a physiologic glucocorticoid and mineralocorticoid level.</p>
      </sec>
      <sec id="article-17183.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Addison disease is caused by an inability of the adrenal cortices to produce adequate adrenocortical hormones. The condition is classified as primary or secondary adrenal insufficiency.<xref ref-type="bibr" rid="article-17183.r4">[4]</xref></p>
        <p>
<bold>Primary Adrenal Insufficiency</bold>
</p>
        <p>Any disease process that causes direct injury to the adrenal cortex can result in primary adrenal insufficiency (ie, Addison disease), including autoimmune, infectious, hemorrhagic, pharmacologic, and infiltrative etiologies.&#x000a0;</p>
        <p>
<bold>Autoimmune </bold>
</p>
        <p>Autoimmune destruction of the adrenal glands is the most common cause of Addison's disease.<xref ref-type="bibr" rid="article-17183.r5">[5]</xref>&#x000a0;This destruction occurs as antibodies develop against the adrenal cortex.<xref ref-type="bibr" rid="article-17183.r6">[6]</xref> Autoimmune destruction can be an isolated finding&#x000a0;or type 1 and 2 autoimmune polyglandular endocrinopathies. Patients with autoimmune adrenal disease are more likely to have polyglandular autoimmune syndromes.<xref ref-type="bibr" rid="article-17183.r7">[7]</xref><xref ref-type="bibr" rid="article-17183.r8">[8]</xref><xref ref-type="bibr" rid="article-17183.r9">[9]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Type 1 autoimmune polyglandular syndrome is manifested by autoimmune polyendocrinopathy, candidiasis, and ectodermal dysplasia. The classic&#x000a0;triad consists of hypoparathyroidism, Addison disease, and mucocutaneous candidiasis.</p>
          </list-item>
          <list-item>
            <p>Type 2 autoimmune polyglandular syndrome is associated with several conditions:
<list list-type="bullet"><list-item><p>Autoimmune thyroiditis (ie, Schmidt syndrome)</p></list-item><list-item><p>Type 1 diabetes (ie, Carpenter syndrome)&#x000a0;<xref ref-type="bibr" rid="article-17183.r10">[10]</xref></p></list-item><list-item><p>Autoimmune conditions (eg, pernicious anemia, vitiligo, or alopecia)</p></list-item><list-item><p>Addison disease has been reported with&#x000a0;celiac disease&#x000a0;<xref ref-type="bibr" rid="article-17183.r11">[11]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Infections</bold>
</p>
        <p>Infectious etiologies include sepsis, tuberculosis, cytomegalovirus, and HIV.<xref ref-type="bibr" rid="article-17183.r12">[12]</xref>&#x000a0;The prevalence of tuberculosis has declined, but HIV has emerged as the most important cause of adrenal insufficiency associated with adrenal necrosis.<xref ref-type="bibr" rid="article-17183.r13">[13]</xref>&#x000a0;Other infectious causes include disseminated fungal infections,&#x000a0;histoplasmosis, and syphilis. Blastomycosis is another cause of Addison disease, particularly in South America.</p>
        <p>
<bold>Adrenal Hemorrhage </bold>
</p>
        <p>DIC, trauma, meningococcemia, and neoplastic processes can precipitate bilateral adrenal hemorrhages. An Adrenal crisis due to meningococcemia is known as the&#x000a0;Waterhouse-Friderichsen syndrome and&#x000a0;is more common in children and patients with asplenia.<xref ref-type="bibr" rid="article-17183.r14">[14]</xref>&#x000a0;</p>
        <p>
<bold>Infiltration</bold>
</p>
        <p>Adrenal infiltration frequently occurs with hemochromatosis,&#x000a0;amyloidosis, and metastases. Other causes include sarcoidosis,&#x000a0;lymphoma, and genetic disorders such as congenital adrenal hyperplasia&#x000a0;and adrenal leukodystrophy.<xref ref-type="bibr" rid="article-17183.r15">[15]</xref><xref ref-type="bibr" rid="article-17183.r16">[16]</xref>&#x000a0;Wolman disease is a rare inborn error of metabolism that presents with diarrhea, hepatosplenomegaly, failure to thrive, and calcification of adrenal glands.<xref ref-type="bibr" rid="article-17183.r17">[17]</xref>&#x000a0;Antiphospholipid antibody syndrome has been identified as a cause of adrenal insufficiency.<xref ref-type="bibr" rid="article-17183.r18">[18]</xref></p>
        <p>
<bold>Medications</bold>
</p>
        <p>Certain pharmacologic etiologies can lead to adrenal insufficiency by blocking cortisol synthesis. For instance, ketoconazole directly inhibits adrenal enzymes, and etomidate can have a dose-dependent effect by selectively inhibiting 11&#x003b2;-hydroxylase, decreasing deoxycortisol conversion to cortisol.<xref ref-type="bibr" rid="article-17183.r19">[19]</xref><xref ref-type="bibr" rid="article-17183.r20">[20]</xref><xref ref-type="bibr" rid="article-17183.r21">[21]</xref></p>
        <p>
<bold>Secondary Adrenal Insufficiency</bold>
</p>
        <p>Secondary insufficiency occurs most commonly due to exogenous steroid administration, resulting in the suppression of ACTH synthesis. Secondary adrenal insufficiency is a pituitary-dependent loss of ACTH secretion, which reduces glucocorticoid production. However, mineralocorticoid secretion, including aldosterone, remains relatively normal.<xref ref-type="bibr" rid="article-17183.r5">[5]</xref>&#x000a0;Secondary adrenal insufficiency is more common than primary insufficiency, with symptoms usually occurring after the discontinuation of a steroid.</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary: autoimmune-mediated&#x000a0;intrinsic adrenal gland dysfunction, which leads to cortisol and aldosterone deficiency</p>
          </list-item>
          <list-item>
            <p>Secondary: chronic glucocorticoid administration resulting in hypothalamic-pituitary dysfunction and cortisol<bold>&#x000a0;</bold>deficiency alone.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Addison's disease is rare, with an incidence of .6 per 100,000 of the population annually. The total number of people affected by this condition&#x000a0;at a given&#x000a0;time ranges from 4 to 11&#x000a0;per 100,000 of the population. In adults, the typical age of Addison disease presentation is 30&#x000a0;to 50 years and is more frequently seen in women.&#x000a0;Risk factors for the autoimmune type of Addison's disease, which is the most common type, include other autoimmune conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I diabetes</p>
          </list-item>
          <list-item>
            <p>Hypoparathyroidism</p>
          </list-item>
          <list-item>
            <p>Hypopituitarism</p>
          </list-item>
          <list-item>
            <p>Pernicious anemia</p>
          </list-item>
          <list-item>
            <p>Graves' disease</p>
          </list-item>
          <list-item>
            <p>Chronic thyroiditis</p>
          </list-item>
          <list-item>
            <p>Dermatis herpetiformis</p>
          </list-item>
          <list-item>
            <p>Vitiligo</p>
          </list-item>
          <list-item>
            <p>Myasthenia gravis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Adrenal failure in Addison disease results in decreased cortisol production initially followed by that of aldosterone, both of which will eventually result in an elevation of adrenocorticotropic (ACTH) and&#x000a0;melanocyte-stimulating hormone (MSH) hormones due to the loss of negative feedback inhibition.<xref ref-type="bibr" rid="article-17183.r22">[22]</xref></p>
      </sec>
      <sec id="article-17183.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Addison disease usually manifests as an insidious and gradual onset of nonspecific symptoms, often resulting in a delayed diagnosis. The symptoms may worsen over a period, which makes early recognition difficult. A high clinical suspicion should be maintained to avoid misdiagnosis.<xref ref-type="bibr" rid="article-17183.r3">[3]</xref>&#x000a0;In many cases, the diagnosis is made only after the patient presents with an acute adrenal crisis manifesting with hypotension, hyponatremia, hyperkalemia, and hypoglycemia. This may be precipitated by a stressful illness or triggering factors such as infection, trauma, surgery, vomiting, or diarrhea.<xref ref-type="bibr" rid="article-17183.r23">[23]</xref>&#x000a0;Significant stress or disease can unmask cortisol and mineralocorticoid deficiency.&#x000a0;</p>
        <p>Addison disease can occur at any age but most often presents during the second or third decades of life. The initial presenting features&#x000a0;include fatigue, generalized weakness, weight loss, nausea, vomiting, abdominal pain, dizziness, tachycardia, and hypotension. Clinicians should also assess for&#x000a0;wasting of subcutaneous tissue. There may be&#x000a0;declining health over several weeks or months.<xref ref-type="bibr" rid="article-17183.r24">[24]</xref>&#x000a0;Due to its variable presentation, a high index of suspicion for Addison disease is necessary when evaluating patients with nonspecific symptoms. These may include unexplained fatigue, poor appetite, chronic abdominal pain, or weight loss. Addisonian crisis is manifested by severe dehydration, confusion, refractory hypotension, and shock and is more likely to occur in primary adrenal insufficiency&#x000a0;than secondary adrenal insufficiency.</p>
        <p>Physical evaluation should include an examination of the skin and mucous membranes for hyperpigmentation.&#x000a0;Hyperpigmentation&#x000a0;of skin and mucous membranes, a hallmark of Addison disease, is usually generalized&#x000a0;and most prominent in sun-exposed and pressure areas.<xref ref-type="bibr" rid="article-17183.r25">[25]</xref>&#x000a0;Specific sites should be carefully evaluated for hyperpigmentation, including the palmar creases, gingival&#x000a0;mucosa, lips, particularly the vermilion border,&#x000a0;elbows, knuckles,&#x000a0;posterior neck, breast areola, nipples, and nail beds. Hyperpigmentation may appear&#x000a0;as bronzing of the skin or diffuse darkening or dark patches and occurs in almost all patients with Addison disease.<xref ref-type="bibr" rid="article-17183.r26">[26]</xref>&#x000a0;However, there have been few reports of patients with adrenal insufficiency without hyperpigmentation. This may delay the diagnosis.<xref ref-type="bibr" rid="article-17183.r27">[27]</xref>&#x000a0;Also, hyperpigmentation is not seen in secondary insufficiency because ACTH&#x000a0;and MSH levels are low.&#x000a0;Elevated ACTH and melanocyte-stimulating hormone are causative factors and are believed to occur due to ACTH binding to the melanocyte receptors responsible for pigmentation. Furthermore, multiple new nevi may develop, and decreased or sparse axillary and pubic hair may occur in female patients.&#x000a0;Vitiligo may also be observed.</p>
      </sec>
      <sec id="article-17183.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnostic Laboratory Studies</bold>
</p>
        <p>The diagnosis of Addison disease is established by demonstrating low cortisol and aldosterone levels, high renin levels, and a&#x000a0;blunt cortisol response with ACTH stimulation. The following is the recommended diagnostic approach for the evaluation of Addison disease.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>An inappropriately low cortisol level&#x000a0;<xref ref-type="bibr" rid="article-17183.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Assessing the adrenal cortex's functional capacity to synthesize cortisol and determine whether the cortisol deficiency is related to a corticotropin (ACTH) deficiency will help to classify whether the adrenal insufficiency is primary or secondary.</p>
          </list-item>
          <list-item>
            <p>Determining whether a treatable cause is present and performing further evaluation should be&#x000a0;directed by its underlying cause.</p>
          </list-item>
        </list>
        <p>
<bold>Cortisol Level</bold>
</p>
        <p>A low random&#x000a0;cortisol level is characteristically seen with Addison disease. Cortisol typically follows a diurnal pattern with the highest level in the early morning; therefore, an early morning level should be obtained. However, getting an early morning cortisol level in the emergency department (ED) is impractical. Furthermore, these results&#x000a0;are not readily available during an ED visit. A single serum cortisol level determination is insufficient to assess adrenal function. However, a morning cortisol level &#x0003e;18 mcg/dL is a normal finding and may exclude an Addison disease diagnosis, while a low cortisol level of &#x0003c;3 mcg/dL is sufficient to diagnose adrenal insufficiency. The following is a summary of cortisol level interpretation.</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal cortisol level: morning cortisol of &#x0003e;18 mcg/dL = Normal</p>
          </list-item>
          <list-item>
            <p>Adrenal insufficiency:&#x000a0;&#x0003c;3 mg/dL</p>
          </list-item>
          <list-item>
            <p>Equivocal; further evaluation recommended:&#x000a0;3 to 19 mcg/dL</p>
          </list-item>
        </list>
        <p>
<bold>ACTH Level and Corticotropin Stimulation Test&#x000a0;</bold>
</p>
        <p>The&#x000a0;ACTH level is markedly elevated in primary adrenal insufficiency. However, the level is not elevated or within the reference range in patients with central adrenal insufficiency. In equivocal cases, the diagnosis&#x000a0;is&#x000a0;confirmed&#x000a0;by an ACTH (ie, cosyntropin) stimulation test, which causes rapid stimulation of cortisol and aldosterone secretion. An ACTH stimulation test is a&#x000a0;first-line diagnostic test for evaluating adrenal insufficiency. Furthermore, plasma cortisol levels should be measured at 0 minutes and 30 to 60 minutes after the administration of ACTH. Corticotropin-releasing hormone (CRH) stimulates ACTH release from the pituitary. In&#x000a0;primary adrenal insufficiency, a high ACTH level is present, which rises further after CRH stimulation; however, serum cortisol secretion cannot be stimulated. Conversely, a low ACTH level is seen in secondary adrenal insufficiency, failing to respond to CRH.&#x000a0;The following is a summary of the interpretation of the ACTH stimulation test.</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary adrenal insufficiency: elevated ACTH</p>
          </list-item>
          <list-item>
            <p>Central adrenal insufficiency: abnormally normal or low ACTH</p>
          </list-item>
        </list>
        <p>With ACTH stimulation</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal response: peak cortisol level &#x0003e;18 mcg/dL&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Adrenal insufficiency: &#x0003c;18 mcg/dL or no response&#x000a0;<xref ref-type="bibr" rid="article-17183.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Aldosterone and Renin Level</bold>
</p>
        <p>Serum renin and aldosterone levels should be obtained to determine whether a mineralocorticoid deficiency is present. Both cortisol and aldosterone are missing in primary adrenal insufficiency. A low aldosterone concentration&#x000a0;is present despite markedly increased plasma renin activity. In secondary&#x000a0;adrenal insufficiency, the aldosterone level will be normal. Increased plasma renin activity can be seen; this indicates that there is adrenal cortex dysfunction. A high level occurs when there is a low level of serum aldosterone.</p>
        <p>
<bold>Comprehensive Metabolic Panel&#x000a0;&#x000a0;</bold>
</p>
        <p>Laboratory findings that are characteristic of Addison disease include hyponatremia, hyperkalemia, and hypoglycemia. Hyponatremia is due to cortisol and aldosterone deficiency. Aldosterone deficiency&#x000a0;causes sodium wasting, and cortisol decreases antidiuretic hormone, leading to increased water absorption. Hypovolemia also triggers ADH secretion. Hyperkalemia is&#x000a0;secondary to low aldosterone levels, which causes natriuresis and potassium retention. However, hyperkalemia<bold>&#x000a0;</bold>does not occur<bold>&#x000a0;</bold>in secondary disease; this helps to&#x000a0;distinguish it from primary adrenal insufficiency. Hypoglycemia is multifactorial, including decreased oral intake and lack of glucocorticoids, which are essential for gluconeogenesis. Hypercalcemia may be present, which&#x000a0;reflects extracellular fluid loss.</p>
        <p>
<bold>Thyroid-stimulating Hormone</bold>
</p>
        <p>A slight elevation of thyroid stimulating hormone (TSH) level can occur in adrenal insufficiency due to decreased cortisol levels and abnormal TSH circadian rhythm.<xref ref-type="bibr" rid="article-17183.r29">[29]</xref>&#x000a0;If TSH elevation persists, clinicians should consider the possibility of hypothyroidism.</p>
        <p>
<bold>Anti&#x02013;21-hydroxylase Antibodies</bold>
</p>
        <p>Anti-adrenal antibodies (eg, 21-hydroxylase antibodies) are the markers of autoimmune destruction of the adrenal gland. The 21-hydroxylase enzyme is essential for cortisol synthesis in the adrenal cortex and can help determine an underlying cause in patients with clinical features of adrenal insufficiency. Anti-adrenal antibodies are also necessary to evaluate other organ-specific autoimmune conditions.&#x000a0;</p>
        <p>
<bold>Diagnostic Imaging Studies</bold>
</p>
        <p>A biochemical diagnosis of adrenal insufficiency should be made before obtaining imaging studies, as radiographic findings are nonspecific. In patients with adrenal insufficiency, a chest radiograph may reveal a small heart, which may be due to a decrease in the cardiac workload. In suspected cases of adrenal hemorrhage, an abdominal computed tomography (CT) scan may provide helpful information in determining the cause. For example,&#x000a0;bilateral enlargement of the adrenal glands may be seen with adrenal hemorrhage. Additionally, adrenal gland calcification or hemorrhage can be seen with tuberculosis.</p>
        <p>Furthermore, a finding on imaging of small adrenal glands suggests autoimmune adrenal destruction.&#x000a0;A magnetic resonance imaging (MRI) of the hypothalamic-pituitary region should be obtained if ACTH is inappropriately low in the presence of cortisol deficiency. A pituitary baseline profile should also be obtained.</p>
        <p>
<bold>Additional Diagnostic Studies</bold>
</p>
        <p>Additional studies&#x000a0;should be directed to determine the underlying cause of adrenal insufficiency. A PPD test should be performed to evaluate for tuberculosis. A serum very long-chain fatty acid profile should be obtained in cases&#x000a0;where adrenal leukodystrophy is suspected. Complete blood count (CBC)&#x000a0;may reveal&#x000a0;neutropenia, lymphocytosis, and eosinophilia. In patients with hyperkalemia, electrocardiograms (ECG) may&#x000a0;show tall and peaked T waves. Histology examination is useful in investigating infiltrative causes of adrenal insufficiency. The finding of caseating granulomas may suggest tuberculosis, whereas&#x000a0;a non-caseating granuloma may be due to sarcoidosis.<xref ref-type="bibr" rid="article-17183.r30">[30]</xref><xref ref-type="bibr" rid="article-17183.r31">[31]</xref></p>
      </sec>
      <sec id="article-17183.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Early recognition is critical for the management of acute adrenal insufficiency. Addison crisis is a severe endocrine emergency; immediate recognition and treatment are required. Addison crisis that is not promptly recognized and treated can be fatal. The confirmatory laboratory evaluation should not delay the treatment. Blood samples should be obtained for subsequent measurement of ACTH and cortisol levels. The elevation of ACTH with low cortisol is diagnostic of a primary adrenal insufficiency. Cortisol in the ACTH stimulation test may be measured when initial laboratory evaluation cannot establish the diagnosis. Plasma renin level is often elevated and indicates a mineralocorticoid deficiency, accompanied by a low aldosterone level.<xref ref-type="bibr" rid="article-17183.r32">[32]</xref><xref ref-type="bibr" rid="article-17183.r33">[33]</xref><xref ref-type="bibr" rid="article-17183.r34">[34]</xref></p>
        <p>
<bold>Acute Phase Therapy</bold>
</p>
        <p>The approach to patients with an adrenal crisis consists of the following components.</p>
        <list list-type="bullet">
          <list-item>
            <p>Fluid resuscitation: to restore&#x000a0;the intravascular volume with intravenous (IV) normal saline&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dextrose: to correct hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Correction of the hormone deficiency: both glucocorticoid and mineralocorticoid</p>
          </list-item>
        </list>
        <p>Hydrocortisone should be immediately administered as the initial hormonal treatment. The recommended adult regimen for adrenal crisis is hydrocortisone 100 mg intravenous (IV) bolus initially, followed by 50&#x000a0;to 100 mg IV every 6 hours over 24 hours. In children, the dosage is&#x000a0;50 mg/m<sup>2</sup>&#x000a0;IV bolus with a maximum dose of 100 mg, followed by 50 to 100 mg/m<sup>2</sup>. Since this&#x000a0;dose has significant mineralocorticoid activity, other mineralocorticoids (eg, fludrocortisone) are unnecessary during the acute phase.<xref ref-type="bibr" rid="article-17183.r35">[35]</xref>&#x000a0;Dexamethasone 4 mg IV bolus can be considered in the ED when&#x000a0;emergent steroid administration is required, as dexamethasone is less likely to interfere with the serum cortisol assays. Dexamethasone is long-acting and does not interfere with biochemical assays of endogenous glucocorticoid production. Prednisone and dexamethasone have little or no mineralocorticoid activity. Initial fluid replacement with a normal saline bolus followed by&#x000a0;5% glucose in isotonic saline is also recommended. Hypoglycemia should be treated promptly.</p>
        <p>
<bold>Maintenance Phase Therapy</bold>
</p>
        <p>In patients with stabilized Addison disease, life-long treatment with hormonal replacement is required. Maintenance therapy aims to provide a replacement&#x000a0;to maintain a physiologic glucocorticoid and mineralocorticoid level. The usual dosage regimens are as follows:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Glucocorticoid
<list list-type="bullet"><list-item><p>Hydrocortisone 5&#x000a0;to 25 mg/day divided into 2 or 3 doses</p></list-item><list-item><p>Prednisone 3&#x000a0;to 5 mg/day</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Doses should be adjusted according to the clinical response and normalization of electrolyte abnormalities. To minimize adverse effects, the dosage should be titrated to the lowest possible dose that controls symptoms; the patient should also be ensured to be clinically well. A plasma renin level can also be used to adjust the doses. Serum ACTH levels may vary significantly and&#x000a0;cannot be used&#x000a0;for dose adjustment. Clinicians should also consider a patient's concurrent medications when deciding the glucocorticoid dose. For example, certain drugs, such as rifampin, can increase hepatic glucocorticoid metabolism and may inactivate cortisol. Dexamethasone is not an appropriate choice for maintenance treatment as the dose titration is challenging and increases the risk of the Cushing effect.<xref ref-type="bibr" rid="article-17183.r36">[36]</xref>&#x000a0;</p>
        <p>Fludrocortisone should be administered at a sufficient dose to keep the plasma renin level in the reference range.<xref ref-type="bibr" rid="article-17183.r37">[37]</xref>&#x000a0;An&#x000a0;elevated PRA indicates a higher dose of fludrocortisone is required. The&#x000a0;mineralocorticoid dosage should be tailored to address the degree of stress. Furthermore, identifying and treating underlying causes such as sepsis is critical for an optimal outcome. The treatment of associated conditions should also be provided.</p>
        <list list-type="bullet">
          <list-item>
            <p>Mineralocorticoid
<list list-type="bullet"><list-item><p>Fludrocortisone .05 to .2 mg daily</p></list-item><list-item><p>Hydrocortisone (in children) 8 mg/m<sup>2</sup>/day orally initially, divided into 3&#x000a0;or 4 doses.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Treatment Considerations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In patients with Addison disease, glucocorticoid secretion does not increase during stress. Therefore, in the presence of fever, infection, or other illnesses, the hydrocortisone dose should be&#x000a0;increased to compensate for a possible stress response.</p>
          </list-item>
          <list-item>
            <p>Generally, a<bold>&#x000a0;</bold>usual hydrocortisone stress dose is 2 to 3 times the daily maintenance dose.<xref ref-type="bibr" rid="article-17183.r38">[38]</xref><bold>&#x000a0;</bold></p>
          </list-item>
          <list-item>
            <p>Patients taking rifampin require an increased dose of hydrocortisone, as&#x000a0;rifampin increases the clearance of hydrocortisone.</p>
          </list-item>
          <list-item>
            <p>Thyroid hormone can increase the hepatic clearance of cortisol, precipitating an adrenal crisis. Glucocorticoid replacement can potentially normalize thyroid-stimulating hormone.</p>
          </list-item>
          <list-item>
            <p>In patients with concomitant diabetes insipidus, glucocorticoid therapy can aggravate diabetes insipidus. Cortisol is required for free-water clearance, and&#x000a0;cortisol deficiency may prevent polyuria.</p>
          </list-item>
          <list-item>
            <p>Pregnancy, particularly during the third trimester, increases corticosteroid requirements.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of adrenal crisis includes most other conditions that can cause shock. The differential diagnosis of adrenal insufficiency is broad, including the following conditions.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Sepsis</bold>:&#x000a0;Many features of sepsis overlap with adrenal insufficiency. The presentation includes weakness, fatigue, vomiting, hypotension, and shock. The primary adrenal insufficiency diagnosis is confirmed by low cortisol response to ACTH stimulation test and low ACTH level.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Shock</bold>: Any type of shock with a decreased serum cortisol level suggests adrenal insufficiency.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Chronic fatigue syndrome</bold>:&#x000a0;Chronic persisting or relapsing fatigue may mimic adrenal insufficiency. However, laboratory evaluations such as cortisol level after corticotropin stimulation differentiate it from adrenal insufficiency.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Infectious mononucleosis</bold>:&#x000a0;The presentation may be similar to fever, fatigue, and myalgias, which may occur in both conditions. However, exudative pharyngitis is present in this condition. IgM antibodies to viral capsid antigens are present.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hypothyroidism</bold>:&#x000a0;As with adrenal insufficiency, fatigue may be present in hypothyroidism. However, hypothyroidism is associated with weight gain. The cortisol level differentiates both conditions.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s10" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>A delay in initiating the treatment can have severe consequences and may&#x000a0;increase rates of morbidity and mortality.<xref ref-type="bibr" rid="article-17183.r39">[39]</xref></p>
      </sec>
      <sec id="article-17183.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The treatment of Addison disease involves a life-long replacement of glucocorticoids and mineralocorticoids. However, most patients live an active life. A strict balance is required to avoid over- or under-treatment with glucocorticoids. Therefore, careful monitoring is needed. Over-treatment with glucocorticoids may result in obesity, diabetes, and osteoporosis.<xref ref-type="bibr" rid="article-17183.r40">[40]</xref>&#x000a0;Over-treatment with mineralocorticoids can&#x000a0;cause hypertension.</p>
        <p>Up to 50% of patients with Addison disease may develop another autoimmune condition; therefore, continued clinical monitoring is recommended.<xref ref-type="bibr" rid="article-17183.r41">[41]</xref>&#x000a0;Thyroid hormone replacement before glucocorticoid administration may precipitate an adrenal crisis in unrecognized patients due to increased cortisol clearance. Rapid recognition and treatment are necessary in acute adrenal crisis.</p>
      </sec>
      <sec id="article-17183.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Several complications can occur due to Addison disease or secondary to inappropriate treatment. Addison disease can progress to an adrenal crisis if not recognized and promptly treated, resulting in hypotension, shock, hypoglycemia, acute cardiovascular decompensation, and death. Patients with adrenal insufficiency are also at higher risk of death due to infections, cancer, and cardiovascular causes.&#x000a0;Delayed recognition and treatment of hypoglycemia can cause serious consequences.<xref ref-type="bibr" rid="article-17183.r42">[42]</xref> A supraphysiologic glucocorticoid replacement can&#x000a0;lead to the development of&#x000a0;Cushing syndrome.<xref ref-type="bibr" rid="article-17183.r39">[39]</xref>&#x000a0;Growth suppression can occur in children.&#x000a0;Premature ovarian failure or primary ovarian insufficiency may develop in up to 10% of women with Addison disease.<xref ref-type="bibr" rid="article-17183.r43">[43]</xref></p>
      </sec>
      <sec id="article-17183.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The treatment plan should be developed in consultation with an endocrinologist.&#x000a0;All patients with an adrenal crisis should be consulted with intensivists and admitted to an intensive care unit (ICU). Patients who are ill-appearing and present with shock should be admitted to ICU.</p>
      </sec>
      <sec id="article-17183.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with Addison disease&#x000a0;should receive education about the management and monitoring of their condition, including:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Medication doses and compliance with the treatment plans, such as increasing&#x000a0;steroid replacement doses in stressful situations such as fever, surgery, or stress&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Having an emergency medical alert bracelet</p>
          </list-item>
          <list-item>
            <p>Self-care, including adequate sodium intake in the diet, weight, and blood pressure monitoring</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to consider regarding Addison disease are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Idiopathic autoimmune adrenocortical insufficiency is the most common cause of Addison disease.</p>
          </list-item>
          <list-item>
            <p>Symptoms of Addison disease can be nonspecific and, therefore, can be challenging to recognize. A high index of suspicion is required to make this diagnosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Serum morning cortisol&#x000a0;&#x0003c;3 mcg/dL with a simultaneous elevation of the plasma ACTH level&#x000a0;&#x0003e;200 pg/mL establishes an Addison disease diagnosis.</p>
          </list-item>
          <list-item>
            <p>Primary adrenal insufficiency diagnosis should be considered in acutely ill patients presenting volume depletion, hypotension, hyponatremia, and hyperkalemia.</p>
          </list-item>
          <list-item>
            <p>Clinicians should consider the possibility of adrenal insufficiency in critically ill patients who failed to improve with resuscitation with fluid administration, particularly in the presence of hyperpigmentation, hyponatremia, or hyperkalemia.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In an Addisonian crisis, treatment is a priority and should not be delayed for diagnostic confirmation; a delayed treatment can be fatal.</p>
          </list-item>
          <list-item>
            <p>The treatment of choice for adrenal crisis is hydrocortisone; this has both glucocorticoid and mineralocorticoid properties.</p>
          </list-item>
          <list-item>
            <p>Glucocorticoid doses should be&#x000a0;increased in the presence of fever, infection, or other stresses.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Titrate the glucocorticoid dose to the lowest possible dose, which can control symptoms and minimize the adverse effects.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Thyroid hormone treatment can precipitate an adrenal crisis since the thyroid hormone can increase the hepatic clearance of cortisol.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Serum cortisol, plasma ACTH, plasma aldosterone, and plasma renin levels should all be obtained before performing the ACTH stimulation test.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Addison disease, due to autoimmune adrenalitis, can develop into another autoimmune disorder.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17183.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Addison disease is a life-threatening condition that requires accurate diagnosis and prompt treatment. A delayed diagnosis carries a high morbidity and mortality. Thus, the condition is best managed by an interprofessional team of healthcare workers, including an endocrinologist, an intensivist, an infectious disease specialist, and a pharmacist. The education of the patient is critical for patients with chronic conditions. Physicians, nurses, and pharmacists can share this responsibility. Nurses need to administer treatments, monitor patients, and provide updates to the team. Once the diagnosis is established, the outcomes depend on the primary cause. Any delay in&#x000a0;initiating the&#x000a0;treatment can&#x000a0;lead to&#x000a0;poor outcomes. All patients&#x000a0;who have Addison disease must be urged to wear a medical alert bracelet. Patients&#x000a0;should be educated regarding the signs and symptoms. They should be urged to contact their&#x000a0;primary care provider if there are any warning symptoms. Finally, in times of stress, such as fever, patients should be instructed to double the dose of steroids and see their primary care provider.<xref ref-type="bibr" rid="article-17183.r44">[44]</xref><xref ref-type="bibr" rid="article-17183.r32">[32]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-17183.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17183&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17183">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/addison-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17183">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17183/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17183">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17183.s18">
        <fig id="article-17183.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Addison's Disease symptoms StatPearls Publishing Illustration</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Addisons_Disease" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17183.s19">
        <title>References</title>
        <ref id="article-17183.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis.</article-title>
            <source>Endocr Pract</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>746</fpage>
            <page-range>746-755</page-range>
            <pub-id pub-id-type="pmid">30084678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choudhury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meeran</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoid replacement in Addison disease.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>562</fpage>
            <pub-id pub-id-type="pmid">29930339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erichsen</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>L&#x000f8;v&#x000e5;s</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Skinningsrud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Undlien</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Svartberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fougner</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Bollerslev</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mella</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Erlich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Husebye</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>4882</fpage>
            <page-range>4882-90</page-range>
            <pub-id pub-id-type="pmid">19858318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bancos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of adrenal insufficiency.</article-title>
            <source>Lancet Diabetes Endocrinol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>216</fpage>
            <page-range>216-26</page-range>
            <pub-id pub-id-type="pmid">25098712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charmandari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nicolaides</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Chrousos</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Adrenal insufficiency.</article-title>
            <source>Lancet</source>
            <year>2014</year>
            <month>Jun</month>
            <day>21</day>
            <volume>383</volume>
            <issue>9935</issue>
            <fpage>2152</fpage>
            <page-range>2152-67</page-range>
            <pub-id pub-id-type="pmid">24503135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bridwell</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>April</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Adrenal Emergencies.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>795</fpage>
            <page-range>795-808</page-range>
            <pub-id pub-id-type="pmid">37758424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michels</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Eisenbarth</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Immunologic endocrine disorders.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>125</volume>
            <issue>2 Suppl 2</issue>
            <fpage>S226</fpage>
            <page-range>S226-37</page-range>
            <pub-id pub-id-type="pmid">20176260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischli</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>[CME: Adrenal Insufficiency].</article-title>
            <source>Praxis (Bern 1994)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>107</volume>
            <issue>13</issue>
            <fpage>717</fpage>
            <page-range>717-725</page-range>
            <pub-id pub-id-type="pmid">29921185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jialal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <chapter-title>Polyglandular Autoimmune Syndrome Type II</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30252248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conrad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Verbakel</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Verbeke</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Molenberghs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sattar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJV</given-names>
              </name>
              <name>
                <surname>McInnes</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Khunti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cambridge</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.</article-title>
            <source>Lancet</source>
            <year>2023</year>
            <month>Jun</month>
            <day>03</day>
            <volume>401</volume>
            <issue>10391</issue>
            <fpage>1878</fpage>
            <page-range>1878-1890</page-range>
            <pub-id pub-id-type="pmid">37156255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Collin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaukinen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>V&#x000e4;lim&#x000e4;ki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salmi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Endocrinological disorders and celiac disease.</article-title>
            <source>Endocr Rev</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>464</fpage>
            <page-range>464-83</page-range>
            <pub-id pub-id-type="pmid">12202461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bachmeier</surname>
                <given-names>CAE</given-names>
              </name>
              <name>
                <surname>Malabu</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Rare case of meningococcal sepsis-induced testicular failure, primary hypothyroidism and hypoadrenalism: Is there a link?</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Sep</month>
            <day>15</day>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">30219775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Collazos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ibarra</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adrenal function in the human immunodeficiency virus-infected patient.</article-title>
            <source>Arch Intern Med</source>
            <year>2002</year>
            <month>May</month>
            <day>27</day>
            <volume>162</volume>
            <issue>10</issue>
            <fpage>1095</fpage>
            <page-range>1095-8</page-range>
            <pub-id pub-id-type="pmid">12020177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Waterhouse-Friderichsen syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Sep</month>
            <day>13</day>
            <volume>345</volume>
            <issue>11</issue>
            <fpage>841</fpage>
            <pub-id pub-id-type="pmid">11556316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirkgoz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Guran</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Primary adrenal insufficiency in children: Diagnosis and management.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-424</page-range>
            <pub-id pub-id-type="pmid">30086866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santosh Rai</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Bhat</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Sekhar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chakraborti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Childhood adrenoleukodystrophy - Classic and variant - Review of clinical manifestations and magnetic resonance imaging.</article-title>
            <source>J Pediatr Neurosci</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>192</fpage>
            <page-range>192-7</page-range>
            <pub-id pub-id-type="pmid">24470810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westra</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Zaninovic</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Kangarloo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boechat</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>Imaging of the adrenal gland in children.</article-title>
            <source>Radiographics</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1323</fpage>
            <page-range>1323-40</page-range>
            <pub-id pub-id-type="pmid">7855344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Espinosa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cervera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>de la Red</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gil</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Font</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Couch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ingelmo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asherson</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-18</page-range>
            <pub-id pub-id-type="pmid">12640187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartle</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Peel</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Etomidate puts patients at risk of adrenal crisis.</article-title>
            <source>BMJ</source>
            <year>2012</year>
            <month>Nov</month>
            <day>06</day>
            <volume>345</volume>
            <fpage>e7444</fpage>
            <pub-id pub-id-type="pmid">23131303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson Bastin</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Weant</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Effects of etomidate on adrenal suppression: a review of intubated septic patients.</article-title>
            <source>Hosp Pharm</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-83</page-range>
            <pub-id pub-id-type="pmid">24623871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tucker</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Snell</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Island</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Gregg</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Reversible adrenal insufficiency induced by ketoconazole.</article-title>
            <source>JAMA</source>
            <year>1985</year>
            <month>Apr</month>
            <day>26</day>
            <volume>253</volume>
            <issue>16</issue>
            <fpage>2413</fpage>
            <page-range>2413-4</page-range>
            <pub-id pub-id-type="pmid">3981770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cottrell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Addison's disease: identification and management in primary care.</article-title>
            <source>Br J Gen Pract</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>65</volume>
            <issue>638</issue>
            <fpage>488</fpage>
            <page-range>488-90</page-range>
            <pub-id pub-id-type="pmid">26324491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouachour</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tirot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varache</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gouello</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Harry</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alquier</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hemodynamic changes in acute adrenal insufficiency.</article-title>
            <source>Intensive Care Med</source>
            <year>1994</year>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-41</page-range>
            <pub-id pub-id-type="pmid">8201094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Druce</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Quality of life in patients with adrenal disease: A systematic review.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>119</fpage>
            <page-range>119-128</page-range>
            <pub-id pub-id-type="pmid">29672878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hyperpigmentation as a clue to Addison disease.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>498</fpage>
            <page-range>498-499</page-range>
            <pub-id pub-id-type="pmid">37907439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thawabteh</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jibreen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thawabteh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karaman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skin Pigmentation Types, Causes and Treatment-A Review.</article-title>
            <source>Molecules</source>
            <year>2023</year>
            <month>Jun</month>
            <day>18</day>
            <volume>28</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">37375394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giannakopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sertedaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Efthymiadou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chrysis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Addison's disease without hyperpigmentation in pediatrics: pointing towards specific causes.</article-title>
            <source>Hormones (Athens)</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-148</page-range>
            <pub-id pub-id-type="pmid">36348260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickstein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shechner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Rosner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shen-Orr</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Adawi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lahav</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1991</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>773</fpage>
            <page-range>773-8</page-range>
            <pub-id pub-id-type="pmid">2005201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samuels</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>85</volume>
            <issue>4</issue>
            <fpage>1388</fpage>
            <page-range>1388-93</page-range>
            <pub-id pub-id-type="pmid">10770171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herndon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nadeau</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Davidge-Pitts</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Bancos</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Primary adrenal insufficiency due to bilateral infiltrative disease.</article-title>
            <source>Endocrine</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>721</fpage>
            <page-range>721-728</page-range>
            <pub-id pub-id-type="pmid">30178435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kagami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kashiwakuma</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iwamoto</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis Presenting Addison's Disease.</article-title>
            <source>Intern Med</source>
            <year>2016</year>
            <volume>55</volume>
            <issue>9</issue>
            <fpage>1223</fpage>
            <page-range>1223-8</page-range>
            <pub-id pub-id-type="pmid">27150885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guignat</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic patient education in adrenal insufficiency.</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>167</fpage>
            <page-range>167-173</page-range>
            <pub-id pub-id-type="pmid">29606279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chanson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Guignat</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Goichot</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chabre</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Boustani</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Reynaud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tabarin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gruson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reznik</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Raffin Sanson</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis.</article-title>
            <source>Ann Endocrinol (Paris)</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>78</volume>
            <issue>6</issue>
            <fpage>495</fpage>
            <page-range>495-511</page-range>
            <pub-id pub-id-type="pmid">29174200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wass</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>How to avoid precipitating an acute adrenal crisis.</article-title>
            <source>BMJ</source>
            <year>2012</year>
            <month>Oct</month>
            <day>09</day>
            <volume>345</volume>
            <fpage>e6333</fpage>
            <pub-id pub-id-type="pmid">23048013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amrein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Martucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hahner</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Understanding adrenal crisis.</article-title>
            <source>Intensive Care Med</source>
            <year>2018</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>652</fpage>
            <page-range>652-655</page-range>
            <pub-id pub-id-type="pmid">29075801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <collab>Society for Endocrinology Clinical Committee</collab>
            </person-group>
            <article-title>SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients.</article-title>
            <source>Endocr Connect</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>G1</fpage>
            <page-range>G1-G3</page-range>
            <pub-id pub-id-type="pmid">27935813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oelkers</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Diederich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>B&#x000e4;hr</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>259</fpage>
            <page-range>259-64</page-range>
            <pub-id pub-id-type="pmid">1320051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michels</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michels</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Addison disease: early detection and treatment principles.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Apr</month>
            <day>01</day>
            <volume>89</volume>
            <issue>7</issue>
            <fpage>563</fpage>
            <page-range>563-8</page-range>
            <pub-id pub-id-type="pmid">24695602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bornstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Allolio</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arlt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Barthel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Don-Wauchope</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Husebye</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Merke</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Stratakis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>364</fpage>
            <page-range>364-89</page-range>
            <pub-id pub-id-type="pmid">26760044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chantzichristos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Eliasson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Johannsson</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>MANAGEMENT OF ENDOCRINE DISEASE Disease burden and treatment challenges in patients with both Addison's disease and type 1 diabetes mellitus.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>183</volume>
            <issue>1</issue>
            <fpage>R1</fpage>
            <page-range>R1-R11</page-range>
            <pub-id pub-id-type="pmid">32299062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zelissen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Bast</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Croughs</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Associated autoimmunity in Addison's disease.</article-title>
            <source>J Autoimmun</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-30</page-range>
            <pub-id pub-id-type="pmid">7734032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Baranowski</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Sakremath</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saraff</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycaemia in adrenal insufficiency.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1198519</fpage>
            <pub-id pub-id-type="pmid">38053731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schoemaker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Drexhage</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Premature ovarian failure and ovarian autoimmunity.</article-title>
            <source>Endocr Rev</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-34</page-range>
            <pub-id pub-id-type="pmid">9034788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17183.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milenkovic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Markovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zdravkovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peric</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Milenkovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vukovic</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Adrenal crisis provoked by dental infection: case report and review of the literature.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>110</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-9</page-range>
            <pub-id pub-id-type="pmid">20674414</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
